March 25th 2024
Developed by the AUGS Scientific Committee and Research Agenda Writing Group
February 23rd 2024
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies
View More
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Perspectives in Prostate Chemoprevention
September 1st 2003Chemoprevention is the use of natural or synthetic agents to avert the induction of, or to inhibit, delay, or suppress the progression of cancers or other diseases. Carcinogenesis is a process that occurs over a period of months to years and is under the influence of a range of genetic and environmental factors.
Managing prostatitis requires a multi-faceted approach
September 1st 2003Although antibiotics are commonly used to treat symptoms of chronic pelvicpain syndrome, this approach is beneficial in a relatively small subsetof patients, and urologists must consider alternative treatment modalities,including physical therapy. In this exclusive Urology Times interview, JeannettePotts, MD, discusses current research and her own views on the diagnosisand treatment of chronic prostatitis. Dr. Potts is a member of the staffat the Cleveland Clinic Glickman Urological Institute. The interview wasconducted by Philip M. Hanno, MD, of the department of urology, Universityof Pennsylvania, Philadelphia.
Endothelin receptor antagonist reduces markers of PCa
September 1st 2003Chicago-The selective endothelin receptor antagonist atrasentan significantly attenuates changes in biochemical markers of bone metabolism and disease progression in a group of patients with advanced hormone-refractory prostate cancer that had progressed on placebo, according to the results of a randomized clinical trial.
Decreased sperm density is linked to DNA damage
April 30th 2003Chicago-The etiology of male factor infertility remains one ofthe larger mysteries confronting urologists. A study from Baylor Collegeof Medicine suggests that the origins of the problem might lie with thetestes and may not involve either inflammation or oxidative radicals, assome have suggested.
Post-prostatectomy sildenafil improves erectile function recovery
April 29th 2003Chicago-Radical prostatectomy patients taking sildenafil postoperativelywere seven times more likely to report a return to spontaneous erectionsthan those taking placebo in a multi-institutional, double-blind study presentedhere yesterday.
Cesarean birth appears to reduce risk of stress incontinence
April 28th 2003Chicago-Women who undergo cesarean section without a trial of labor appearto be significantly less likely to experience stress urinary incontinencethan those who deliver vaginally or underwent a CS for obstructed labor,according to a study from Israel.
Six weeks of antibiotics improves chronic prostatitis symptoms
April 28th 2003Chicago-Six weeks of antimicrobial therapy with levofloxacin (Levaquin)appears to improve symptoms of chronic prostatitis/chronic pelvic pain syndromein men, although the benefits are not sustained, according to a Canadianstudy presented yesterday.
Testosterone gel increases sexual activity, bone density
April 1st 2003Auxilium Pharmaceuticals, Inc., introduces Testim testosterone topicalgel to supplement low levels of testosterone in men with hypogonadism. Duringclinical trials, patients reported a 59% increase in sexual activity anda 78% increase in days with a spontaneous erection over a 90-day period,according to the company. Initial analysis of long-term data suggests thatthe gel also improves bone mineral density.
Managing chronic prostatitis: A modern approach
April 1st 2003Nearly one in 10 men who walk into the outpatient office of a urologist leave with a coded diagnosis of prostatitis. Urologists have described the traditional approach to the diagnosis and management of the chronic prostatitis syndromes as one of the most frustrating areas of urologic practice.
Treat infertile males beyond their reproductive concerns
April 1st 2003One does not have to go far on the Internet to find solicitations encouragingcouples whose infertility derives from a wide variety of causes to undergointracytoplasmic sperm injection with aspirated testicular sperm. Many ofthese advertisements hint that ICSI with aspirated sperm is an easy, "one-stop"method of conceiving a child, leading urologists to be rightly concernedthat, without adequate evaluation of the male half of the equation, thepatient's medical interests are inadequately served.
Antidiuretic found effective in adults with nocturia
March 1st 2003Copenhagen, Denmark-An oral antidiuretic approved for the treatment ofnocturnal enuresis also appears to be effective for treating nocturia inadult men and women, according to phase III clinical trial results reportedby the multinational Nocturia Study Group.
Factors affect fertility prognosis: Studies shed light on histopathology of cryptorchidism
March 1st 2003Boston-Children with myelomeningocele and undescended testis face greaterrisk of infertility than patients with undescended testis alone, accordingto research presented at the American Academy of Pediatrics Section on Urologyannual meeting here. In a related study, researchers found that patientswith defective second step germ cell maturation due to cryptorchidism havea poor fertility prognosis.
Nephron-sparing surgery: Minimally invasive techniques
February 1st 2003Nephron-sparing surgery (NSS) was initially developed as a mechanism to preserve renal function in patients at risk of requiring dialysis in the face of total nephrectomy. Indications included tumors in patients with a solitary kidney, multifocal disease, or chronic renal insufficiency.
Bush pushes national liability reform; PA docs receive short-term relief
January 15th 2003Scranton, PA-Calling the medical liability insurance crisis a"national problem that needs a national solution," President Bushrenewed his support for federal reform that would include a cap on non-economicdamages awarded to injured patients. Meanwhile, urologists and other physiciansthroughout Pennsylvania, the site of Bush's speech, canceled plans to shuttertheir practices after the governor revealed short-term measures aimed atalleviating the crisis.
Think twice about how you evaluate, treat recurrent UTIs
January 1st 2003Recurrent urinary tract infections are so common in our female patientsthat urologists and other clinicians give little thought to their evaluationand treatment. However, new research findings may lead to some small butimportant changes in our approach to this prevalent urologic problem.